Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
17.23%
EBIT Growth (5y)
18.48%
EBIT to Interest (avg)
29.20
Debt to EBITDA (avg)
1.33
Net Debt to Equity (avg)
0.26
Sales to Capital Employed (avg)
0.79
Tax Ratio
19.29%
Dividend Payout Ratio
2.16%
Pledged Shares
0
Institutional Holding
24.84%
ROCE (avg)
20.58%
ROE (avg)
15.98%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
47
Industry P/E
37
Price to Book Value
6.18
EV to EBIT
35.78
EV to EBITDA
27.43
EV to Capital Employed
5.10
EV to Sales
7.12
PEG Ratio
3.49
Dividend Yield
NA
ROCE (Latest)
13.26%
ROE (Latest)
12.39%
Loading Valuation Snapshot...
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Sideways
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
Mildly Bearish
Mildly Bearish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend19What is working for the Company
OPERATING CF(Y)
Highest at Rs 2,751.99 Cr
OPERATING PROFIT TO INTEREST(Q)
Highest at 9.60 times
PAT(Latest six months)
At Rs 1,142.07 cr has Grown at 32.38%
PBT LESS OI(Q)
Highest at Rs 724.45 cr.
DPS(Y)
Highest at Rs 1.00
DPR(Y)
Highest at 2.03%
NET SALES(Q)
Highest at Rs 4,030.59 cr
PBDIT(Q)
Highest at Rs 1,056.19 cr.
EPS(Q)
Highest at Rs 13.75
-2What is not working for the Company
CASH AND CASH EQUIVALENTS(HY)
Lowest at Rs 482.77 cr
Loading Valuation Snapshot...
Here's what is working for Mankind Pharma
Operating Profit to Interest - Quarterly
Highest at 9.60 times and Grown
each quarter in the last five quartersMOJO Watch
The company's ability to manage interest payments is improving
Operating Profit to Interest
Operating Cash Flow - Annually
Highest at Rs 2,751.99 Cr and Grown
each year in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (Rs Cr)
Profit Before Tax less Other Income (PBT) - Quarterly
Highest at Rs 724.45 cr. and Grown
each quarter in the last five quartersMOJO Watch
Near term PBT trend is very positive
PBT less Other Income (Rs Cr)
Profit After Tax (PAT) - Latest six months
At Rs 1,142.07 cr has Grown at 32.38%
Year on Year (YoY)MOJO Watch
Near term PAT trend is positive
PAT (Rs Cr)
Net Sales - Quarterly
Highest at Rs 4,030.59 cr
in the last five quartersMOJO Watch
Near term sales trend is positive
Net Sales (Rs Cr)
Operating Profit (PBDIT) - Quarterly
Highest at Rs 1,056.19 cr.
in the last five quartersMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (Rs Cr)
Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 724.45 cr has Grown at 37.8% (vs previous 4Q average)
over average PBT of the previous four quarters of Rs 525.91 CrMOJO Watch
Near term PBT trend is positive
PBT less Other Income (Rs Cr)
Earnings per Share (EPS) - Quarterly
Highest at Rs 13.75
in the last five quartersMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (Rs)
Dividend per Share (DPS) - Annually
Highest at Rs 1.00
in the last five yearsMOJO Watch
Company is distributing higher dividend from profits generated
DPS (Rs)
Dividend Payout Ratio (DPR) - Annually
Highest at 2.03%
in the last five yearsMOJO Watch
Company is distributing higher proportion of profits generated as dividend
DPR (%)
Here's what is not working for Mankind Pharma
Cash and Cash Equivalents - Half Yearly
Lowest at Rs 482.77 cr
in the last six half yearly periodsMOJO Watch
Short Term liquidity is deteriorating
Cash and Cash Equivalents
